Clinical Trial Update: Psychosomatic Risk Screening [NA]

View source ↗

Summary

The trial update notes that Heidelberg University’s psychosomatic risk screening study in patients with cardiovascular diseases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Snippet

Sponsor: Heidelberg University | Conditions: Cardiovascular Diseases | NA | Status: COMPLETED